Hennion & Walsh Asset Management, Inc.
Position in JNJ — Johnson & Johnson
CIK 1861642
Parsippany, NJ
Position in JNJ
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$11,112,457
+$1,048,374 QoQ
Shares Held
43,755
+6.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#29
of 321 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 97.40372528853845.ToString("F0")%
Shared 0.ToString("F0")%
None 2.596274711461547.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $55,949,166 across 10 Drug Manufacturers - General names. JNJ ranks #2 (19.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,360 | $17,223,816 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
43,755 | $11,112,457 | |
| 3 | MRK |
Merck & Co., Inc.
|
72,515 | $9,318,177 | |
| 4 | ABBV |
AbbVie Inc.
|
23,832 | $5,997,084 | |
| 5 | GRFS |
Grifols SA
|
592,173 | $4,192,584 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
28,507 | $3,601,574 | |
| 7 | AMGN |
Amgen Inc
|
7,665 | $2,775,649 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
18,045 | $1,039,752 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,112,457 | 43,755 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $10,064,083 | 41,172 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,513,095 | 41,136 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $7,185,766 | 38,754 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $4,972,165 | 32,551 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,756,140 | 34,709 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $5,483,267 | 37,915 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $5,917,945 | 36,517 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $5,747,742 | 39,325 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $6,430,107 | 40,648 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $6,890,133 | 43,959 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $6,393,537 | 41,050 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $8,620,778 | 52,083 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $7,668,470 | 49,474 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $9,428,340 | 53,373 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $8,125,853 | 49,742 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,987,331 | 50,630 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $7,907,648 | 44,618 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $6,130,464 | 35,836 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,002,462 | 30,975 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,755,248 | 22,795 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,722,691 | 22,651 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||